Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Allergan Inc., consolidated balance sheet: assets

US$ in thousands

	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cash and equivalents	4,911,400)	3,046,100)	2,701,800)	2,406,100)	1,991,200)
Short-term investments	55,000)	603,000)	260,600)	179,900)	749,100)
Trade receivables, net	914,500)	883,300)	764,200)	730,600)	647,300)
Inventories	296,000)	285,300)	282,900)	249,700)	229,400)
Prepaid expenses	218,400)	157,100)	149,900)	99,800)	64,700)
Deferred taxes	343,500)	277,900)	249,100)	305,600)	277,700)
Foreign currency derivative assets	75,100)	20,400)	—)	—)	—)
Other	57,300)	37,600)	50,300)	76,600)	34,300)
Other current assets	694,300)	493,000)	449,300)	482,000)	376,700)
Assets of discontinued operations	—)	9,000)	—)	—)	—)
Current assets	6,871,200)	5,319,700)	4,458,800)	4,048,300)	3,993,700)
Deferred executive compensation investments	112,900)	100,700)	81,700)	70,900)	64,900)
Capitalized software	37,000)	36,800)	47,300)	57,800)	75,300)
Prepaid pensions	11,100)	5,600)	5,700)	3,500)	7,500)
Prepaid royalties	—)	—)	—)	4,900)	8,500)
Interest rate swap fair value	—)	—)	—)	48,100)	42,300)
Debt issuance costs	8,600)	10,800)	8,000)	9,500)	10,000)
Equity investments	47,200)	20,800)	9,000)	9,000)	7,700)
Other	55,100)	38,500)	40,400)	43,400)	45,200)
Investments and other assets	271,900)	213,200)	192,100)	247,100)	261,400)
Deferred tax assets	86,900)	128,800)	206,900)	152,600)	217,800)
Property, plant and equipment, net	1,006,300)	923,200)	852,900)	807,000)	800,600)
Goodwill	2,392,900)	2,339,400)	2,239,500)	2,088,400)	2,038,600)
Intangibles, net	1,786,500)	1,650,000)	1,229,100)	1,165,200)	996,000)
Non-current assets	5,544,500)	5,254,600)	4,720,500)	4,460,300)	4,314,400)
Total assets	12,415,700)	10,574,300)	9,179,300)	8,508,600)	8,308,100)

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

Total assets exhibited a consistent upward trajectory from 2010 to 2014, growing from 8.31 billion USD to 12.42 billion USD. This represents a total increase of approximately 49.5% over the five-year period, with the most significant acceleration in growth occurring between 2012 and 2014.

Current Asset Expansion and Liquidity: Current assets grew from 3.99 billion USD in 2010 to 6.87 billion USD in 2014. The primary driver of this expansion was the substantial increase in cash and equivalents, which rose from 1.99 billion USD to 4.91 billion USD. While short-term investments fluctuated significantly, ending at a low of 55 million USD in 2014, the overall liquidity position strengthened considerably. Trade receivables and inventories showed steady, incremental growth, suggesting a scaling of operational volume.
Intangible Asset and Goodwill Trends: Non-current assets increased from 4.31 billion USD to 5.54 billion USD. A significant portion of this growth is attributed to intangible assets, net, which surged from 996 million USD in 2010 to 1.79 billion USD in 2014, with a notable jump between 2012 and 2013. Goodwill also experienced a steady climb from 2.04 billion USD to 2.39 billion USD. The combined growth in these categories indicates a strategic focus on acquisitions or the acquisition of intellectual property.
Fixed Assets and Long-term Investments: Property, plant, and equipment, net, demonstrated a consistent year-over-year increase, crossing the 1 billion USD threshold by 2014. Conversely, deferred tax assets showed a general downward trend, decreasing from 217.8 million USD in 2010 to 86.9 million USD in 2014, suggesting a realization of these assets or changes in tax positioning over the period.
Other Asset Observations: Deferred executive compensation investments grew steadily from 64.9 million USD to 112.9 million USD. Additionally, the appearance of foreign currency derivative assets starting in 2013, reaching 75.1 million USD by 2014, points to an increased utilization of hedging strategies to manage currency risk in later years.

Allergan Inc. (NYSE:AGN.)

Balance Sheet: Assets

Assets: Selected Items

Current Assets: Selected Items